canvax – Page 3 – Amal Therapeutics

About canvax

This author has yet to write their bio.
Meanwhile lets just say that we are proud canvax contributed a whooping 23 entries.

Entries by canvax

Amal Therapeutics raises seed round from Boehringer Ingelheim Venture Fund and High-Tech Gründerfonds

1st February 2014 in News /by canvax

Geneva/Berlin/Ingelheim/Bonn, 20th February 2014. Amal Therapeutics SA, a Swiss and German-based company focusing on the development of therapeutic cancer vaccines, announced today that it has closed its seed financing round. The funds will be used to consolidate the cell-penetrating peptide based technology platform and progress the first vaccine candidate up to pre-clinical development. The investment […]

Amal Therapeutics received the support from the “Eidgenössische Stiftung zur Förderung Schweizerische Volkswirtschaft durch wissenschaftlische Forschung”

1st June 2013 in News /by canvax

Amal Therapeutics received the support from the “Eidgenössische Stiftung zur Förderung Schweizerische Volkswirtschaft durch wissenschaftlische Forschung”.

Amal Therapeutics received a CTI grant for a research project in collaboration with the Laboratory of Tumor Immunology, University of Geneva

1st May 2013 in News /by canvax

Amal Therapeutics received a CTI grant for a research project in collaboration with the Laboratory of Tumor Immunology, University of Geneva.